CRIP1 and ependymoma: Moreover, CRIP1 has prognostic significance in prostate cancer [79], hypertension-related renal cell carcinoma [80], ependymoma [81], etc. Studies have shown that in prostate cancer, the hypomethylation level of the CRIP1 promoter is associated with poor prognosis [82].